GILAD OREN (President) received a stock award from APREA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/31/2025ACC: 0001104659-25-029914
DirectorOfficer· President
Since May 2022
+33.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.63K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.72K
Price / share
—
Trade value
—
% of position
2.0%
3/27/2025
333.39K→340.12K
Total
Net shares
+6.72K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2025 | A · Award | +6.72K | — | — | 2.0% | 333.39K | 340.12K |
| Total | +6.72K | $0.00 | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
26.90K shares
Shares
+26.90K
Strike price
2.20
Held after
26.90K
Exercisable
—
3/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock26.90K shares | 3/27/2025 | A · Award | +26.90K | 2.20 | — | 26.90K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned600.00
Common Stock
IndirectShares owned1.20K
Total
1.80K indirect1.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 600.00 | Indirect |
| Common Stock | 1.20K | Indirect |
| Total | 1.80K | 1.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported